Latest DURAGESIC Stories
DALLAS, February 10, 2015 /PRNewswire/ -- ReportsnReports.com adds Global & USA Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor
PITTSBURGH, April 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc.
The law firm of Heygood, Orr & Pearson is announcing the launch of its new fentanyl pain patch website, Fentanyl Patch Lawsuits (http://fentanylpatchlawsuits.com/).
As updated on November 27th, 2012 by the American Society of Health-System Pharmacists, Fentanyl Injection 50 mcg/mL shortages are reported.
The US FDA announced on its June 6th, 2012 enforcement report that J&J recalled more than 53,000 Duragesic (Fentanyl Transdermal System) patches because of crystallization.
According to court documents, on June 19th, 2012, Tracy King filed a wrongful death claim at Philadelphia’s Common Pleas Court (case no.
On April 19th, 2012 the US FDA issued a safety alert to warn patients, caregivers and health care professionals about the dangers of accidental exposure to and improper storage and disposal of
As published on March 27th, 2012 in the Pharmaceutical Business Review, Insys Therapeutics launched Subsys (Fentanyl sublingual spray) for the management of persistent cancer pain.